IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.48M	$42.69M	-
Other	Geffner Michael	218.0K	$6.31M	-
Other	Stout Jay S	199.7K	$5.78M	-
COO	Gloria Melanie	175.9K	$5.09M	-
Other	Van Tuyl Christopher	152.2K	$4.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 23, 2025	Stout Jay S63	Chief Technology Officer	Sell	2,805	$18.15	$50,910.75	-1.4%	+4.6%	-
Jul 23, 2025	Geffner Michael66	Chief Medical Officer	Sell	2,385	$18.15	$43,287.75	-1.1%	+4.6%	-
Jul 9, 2025	Geffner Michael66	Chief Medical Officer	Sell	1,160	$17.24	$19,998.40	-0.5%	-6.8%	-
Jul 9, 2025	Stout Jay S63	Chief Technology Officer	Sell	1,519	$17.24	$26,187.56	-0.7%	-6.8%	-
Apr 23, 2025	Stout Jay S63	Chief Technology Officer	Sell	1,925	$14.79	$28,470.75	-0.9%	+24.2%	-
Apr 23, 2025	Geffner Michael66	Chief Medical Officer	Sell	2,349	$14.79	$34,741.71	-1.0%	+24.2%	-
Apr 16, 2025	Barnett Eva Renee58	Chief Financial Officer	Sell	2,993	$14.89	$44,565.77	-0.7%	+17.9%	-
Apr 16, 2025	Salzmann Peter51	Chief Executive Officer	Sell	8,321	$14.89	$123,899.69	-0.7%	+17.9%	-
Apr 9, 2025	Stout Jay S63	Chief Technology Officer	Sell	5,004	$12.99	$65,001.96	-2.3%	+13.4%	+72.1%
Apr 9, 2025	Geffner Michael66	Chief Medical Officer	Sell	6,169	$12.99	$80,135.31	-2.6%	+13.4%	+72.1%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC